A5016023127- Breast Cancer Treatment Studies
- Advanced Radiotherapy Techniques
- Cancer Treatment and Pharmacology
- Lung Cancer Diagnosis and Treatment
- Advances in Oncology and Radiotherapy
- Breast Lesions and Carcinomas
- Cancer Cells and Metastasis
- Breast Implant and Reconstruction
- Lung Cancer Treatments and Mutations
- Esophageal Cancer Research and Treatment
- Nanoplatforms for cancer theranostics
- Sarcoidosis and Beryllium Toxicity Research
- Ginkgo biloba and Cashew Applications
- Hair Growth and Disorders
- Bone Metabolism and Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Dementia and Cognitive Impairment Research
- Advanced Breast Cancer Therapies
- Multiple and Secondary Primary Cancers
- Acne and Rosacea Treatments and Effects
- Growth Hormone and Insulin-like Growth Factors
- HER2/EGFR in Cancer Research
- Cancer Diagnosis and Treatment
- Cytokine Signaling Pathways and Interactions
- Nonmelanoma Skin Cancer Studies
Taian City Central Hospital
2025
Army Medical University
2025
Daping Hospital
2025
Fudan University Shanghai Cancer Center
2014-2024
Shanghai Medical College of Fudan University
2013-2024
Fudan University
2015-2024
Chongqing Medical University
2024
Merck & Co., Inc., Rahway, NJ, USA (United States)
2019
The traditional Chinese medicine compound preparation known as Jinbei Oral Liquid (JBOL) consists of 12 herbs, including Astragalus membranaceus (Fisch.) Bge, Codonopsis pilosula (Franch.) Nannf, et al. Having been used for over 30 years in the treatment pulmonary diseases, JBOL was evaluated this study order to assess its effect on idiopathic fibrosis well safety (ChiCTR2000035351, Chictr.org.cn.09/08/2020). A double-blind, multicenter, randomized, proof-of-concept trial conducted efficacy...
Abstract INTRODUCTION This study was undertaken to evaluate the diagnostic performance of a novel plasma phosphorylated tau (p‐tau) 217/amyloid beta (Aβ) 42 ratio test for Alzheimer's disease (AD). METHODS The Lumipulse G p‐tau217/Aβ42 evaluated using Aβ and positron emission tomography (PET) as reference standards in clinic cohort ( n = 391) community 121). RESULTS Plasma exhibited high abnormal statuses PET (area under curve [AUC]: 0.963 0.966) (AUC: 0.947 0.974), which were clinically...
AIM: To investigate the correlation between expression of E-cadherin,β-catenin and CathepsinD, to determine their clinicopai §thologic features in esophageal squamous cell carcinoma (ESCC). METHODS: Sixty surgically excised pathologically confirmed ESCC specimens were selected from preclinical medical college, Xinjiang Medical University June 2003 July 2007, while 15 cases normal tissues taken as control group. Immunohistochemi-cal EnVision method was used E-cadherin, p-catenin CathepsinD 60...